期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多发性骨髓瘤肿瘤干细胞的研究现状 被引量：1

原文传递
导出
摘要 随着自体造血干细胞移植（auto—HSCT）以及硼替佐米、沙利度胺等新药的应用，多发性骨髓瘤（MM）患者的生存期明显延长，但复发仍不可避免。近年来，越来越多的研究表明MM存在的肿瘤干细胞（TSC）可能与疾病的复发有密切联系，对其进行深入研究可能为MM的治疗带来新的突破。
作者 姜鸾 陈文明
机构地区 首都医科大学附属北京朝阳医院血液科
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第4期343-346,共4页 Chinese Journal of Hematology
基金 国家自然科学基金（30872982、81172252）
关键词 多发性骨髓瘤 肿瘤干细胞 自体造血干细胞移植 硼替佐米 沙利度胺 生存期 复发
分类号 R733.3 [医药卫生—肿瘤]
  • 相关文献

参考文献27

  • 1Matsui W,HuffCA,WangQ. Characterization of clonogen-ic multiple myeloma cells[J].Blood,2004.2332-2336.
  • 2Pilarski LM,Seeberger K,Coupland RW. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice[J].Experimental Hematology,2002.221-228.
  • 3Matsui W,Wang Q,Barber JP. Clonogenic multiple myeloma progenitors,stem cell properties,and drug resistance[J].Cancer Research,2008.190-197.
  • 4Ghosh N,Matsui W. Cancer stem cells in multiple myeloma[J].Cancer Letters,2009.1-7.
  • 5Mark PC,Irving LW,Christopher YP. Cancer stem cells:on the verge of clinical translation[J].Laboratory Medicine,2008.679-686.
  • 6Luckey CJ,Bhattacharya D,Goldrath AW. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells[J].Proceedings of the National Academy of Sciences(USA),2006.3304-3309.
  • 7Yaccoby S,Epstein J. The proliferative potential of myeloma plasma cells manifest in the SCID-hu host[J].Blood,1999.3576-3582.
  • 8Pilarski LM,Belch AR. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34(+)hematopoietic progenitors[J].Clinical Cancer Research,2002.3198-3204.
  • 9Svachova H,Pour L,Sana J. Stem cell marker nestin is expressed in plasma cells of multiple myeloma patients[J].Leukemia Research,2011.1008-1013.
  • 10Perez LE,Parquet N,Anasetti C. Phenotypic analysis of multiple myeloma cell progenitors[J].Biology of Blood and Marrow Transplantation,2010.234.

同被引文献14

  • 1Wulf GG, Wang RY, Kuehnle I, et al. A leukemic stem cell withintrinsic drug efflux capacity in acute myeloid leukemia. Blood, 2001; 98(4) :1166 -1173.
  • 2Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells, 2006 ; 24 ( 3 ) :506 - 513.
  • 3Liu BY, McDermott SP, Khwaja SS, et al. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci USA, 2004 ; 101 (12) :4158 -4163.
  • 4Matsui W ,Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood,2004 ; 103 (6) :2332 - 2336.
  • 5Palno T, Ocio EM, Paiva B, et al. CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype. Haematologica, 2012; 97(7) :1110 - 1114.
  • 6Hosen N, Matsuoka Y, Kishida S, et al. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients. Leukemia,2012 ; 26 (9) :2135 - 2141.
  • 7Cruz RD, Tricot G, Zangari M, et al. Progress in myeloma stem cells. Am J Blood Res, 2011; 1(2) :135 -145.
  • 8Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med, 1996; 183(4) :1797 -1806.
  • 9Loh YS, Mo S, Brown RD, et al. Presence of Hoechst low side populations in multiple myeloma. Leuk Lymphoma, 2008 ; 49 (9) : 1813 -1816.
  • 10Jakubikova J, Adamia S, Kost-Alimova M, et al. Lenalidomide targets clonogenic side population in multiple myeloma: pathophy- siologic and clinical implications. Blood, 2011 ; 117 ( 17 ) :4409 - 4419.

引证文献1

二级引证文献4

中华血液学杂志
2012年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部